Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -10.891\% hERG inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: CC1CCN(c2nc3c(c(=O)n(C)c(=O)n3C)n2Cc2ccccc2)CC1
b: Nc1ccc(Oc2ccc(Br)cc2)cc1
c: CC(=O)c1cc(C)ccc1OC(=O)CCN1C(=O)C2C3c4ccccc4C(c4ccccc43)C2C1=O
Answer: c. CC(=O)c1cc(C)ccc1OC(=O)CCN1C(=O)C2C3c4ccccc4C(c4ccccc43)C2C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
(2-acetyl-4-methylphenyl) 3-(16,18-dioxo-17-azapentacyclo[6.6.5.02,7.09,14.015,19]nonadeca-2,4,6,9,11,13-hexaen-17-yl)propanoate